無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

粉末吸入器の世界市場予測:種類、治療対象、地域別の予測

Dry Powder Inhaler Devices Market: By Type (Capsule Based, Blister Based, Reservoir/Cartridge Based); By Therapeutics (Upper Respiratory, Asthma, COPD, Diabetes, Hereditary Diseases, Cystic Fibrosis and others) & By Region-Forecast (2016-2022)

発行 IndustryARC 商品コード 422737
出版日 ページ情報 英文 176 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.47円で換算しております。
Back to Top
粉末吸入器の世界市場予測:種類、治療対象、地域別の予測 Dry Powder Inhaler Devices Market: By Type (Capsule Based, Blister Based, Reservoir/Cartridge Based); By Therapeutics (Upper Respiratory, Asthma, COPD, Diabetes, Hereditary Diseases, Cystic Fibrosis and others) & By Region-Forecast (2016-2022)
出版日: 2016年09月09日 ページ情報: 英文 176 Pages
概要

当レポートでは、粉末吸入器の世界市場について調査し、吸入器の種類、治療法、地域別の市場動向および市場成長予測、市場の促進・抑制要因、市場の課題、競合分析、主要企業のプロファイルなどをまとめています。

第1章 粉末吸入器市場:市場概要

第2章 エグゼクティブサマリー

第3章 粉末吸入器市場:市場情勢

  • 市場シェア分析
  • 競合分析
  • 製品ベンチマーク
  • エンドユーザーのプロファイル
  • 上位5社の財務分析

第4章 市場力学

  • 市場の抑制要因
  • 市場の課題
  • ファイブフォース分析

第5章 粉末吸入器市場:戦略分析

  • バリューチェーン分析
  • 価格分析
  • 市場機会分析
  • 製品/市場のライフサイクル分析
  • 供給・流通

第6章 粉末吸入器市場:種類別

  • カプセルベース
  • ブリスターベース
  • 容器・カートリッジベース
  • その他

第7章 粉末吸入器市場:治療法別

  • 上気道
  • 喘息
  • 慢性閉塞性肺疾患(COPD)
  • 糖尿病
  • 遺伝性疾患
  • 嚢胞性線維症(CF)
  • 感染疾患
  • 骨粗しょう症
  • 神経学
  • 疼痛管理
  • その他

第8章 粉末吸入器市場:地域別

  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • 英国
    • その他の国々
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他の国々
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • その他の地域
    • ブラジル
    • その他の地域

第9章 粉末吸入器市場:エントロピー

  • 市場の拡大
  • 技術の進展
  • 合併・買収・合弁事業
  • 供給契約

第10章 企業プロファイル

目次

Dry-powder inhaler (DPI) is an alternative device to the aerosol-based inhalers commonly called metered-dose inhaler (or MDI) and help in delivering medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD, although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus. Globally, increasing number of people with respiratory diseases and diabetes mellitus are expected to remain the growth drivers for dry powder inhaler devices during the period of study.

Dry Powder Inhaler Devices Market

Geographically, North America dominated the dry powder inhaler devices market driven by a world class healthcare infrastructure with a technologically advanced practice, higher spending, a high number of people with respiratory problems, strict guidelines and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for dry powder inhaler devices market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the dry powder inhaler devices market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the dry powder inhaler devices market.

This report segments the dry powder inhaler devices market on the basis of type, therapeutics and regional market as follows:

Dry powder inhaler devices market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Capsule Based Dry Powder Inhaler Device, Blister Based Powder Inhaler Device, Reservoir/Cartridge Based Powder Inhaler Device and Others

Dry powder inhaler devices market research report is classified on the basis of therapeutics. Some of the major therapeutics covered in this report are as follows: Upper Respiratory, Asthma, COPD, Diabetes, Hereditary Diseases, Cystic Fibrosis, Infectious Diseases, Osteoporosis, Neurology, Pain Management

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the dry powder inhaler devices market. Some of the major companies' profiles in detail are as follows:

Bayer HealthCare AG Company

GlaxoSmithKline Plc

Sandoz International GmbH

Teva Pharmaceutical Industries Ltd.

Novartis AG

Table of Contents

1. Dry powder inhaler devices Market - Overview

2. Executive Summary

3. Dry powder inhaler devices Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Dry powder inhaler devices Market- Forces

  • 4.1. Drivers
    • 4.1.1. Increasing population with respiratory problems
    • 4.1.2. Technological advancement
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Dry powder inhaler devices Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Dry powder inhaler devices Market, By Type

  • 6.1. Capsule Based
  • 6.2. Blister Based
  • 6.3. Reservoir/Cartridge Based
  • 6.4. Others

7. Dry powder inhaler devices Market, By Therapeutics

  • 7.1. Upper Respiratory
  • 7.2. Asthma
  • 7.3. COPD
  • 7.4. Diabetes
  • 7.5. Hereditary Diseases
  • 7.6. Cystic Fibrosis
  • 7.7. Infectious Diseases
  • 7.8. Osteoporosis
  • 7.9. Neurology
  • 7.10. Pain Management
  • 7.11. Others

8. Dry powder inhaler devices Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Dry powder inhaler devices Market - Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Bayer HealthCare AG Company
  • 10.2. GlaxoSmithKline Plc
  • 10.3. Sandoz International GmbH
  • 10.4. Teva Pharmaceutical Industries Ltd.
  • 10.5. Novartis AG
  • 10.6. AKELA Pharma Inc.
  • 10.7. Pharmaxis Limited
  • 10.8. Hovione FarmaCiencia SA
  • 10.9. Nanotherapeutics, Inc
  • 10.10. OPKO Health, Inc.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top